Daria B Crittenden
Affiliation: New York University School of Medicine
- Colchicine use is associated with decreased prevalence of myocardial infarction in patients with goutDaria B Crittenden
Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
J Rheumatol 39:1458-64. 2012..We examined whether colchicine use was associated with a reduced risk of myocardial infarction (MI) in patients with gout...
- New therapies for goutDaria B Crittenden
Crystal Diseases Study Group, Division of Rheumatology, Department of Medicine, NYU School of Medicine NYU Langone Medical Center, New York, New York 10003, USA
Annu Rev Med 64:325-37. 2013..These new treatments do not obviate the need for lifestyle and dietary management, another area in which significant scientific and clinical progress has recently been made...
- Prevalence of contraindications and prescription of pharmacologic therapies for goutRobert T Keenan
Section of Rheumatology of the New York Harbor Health Care System, New York Campus of the US Department of Veterans Affairs, New York, USA
Am J Med 124:155-63. 2011..Patients with gout have comorbidities, but the impact of these comorbidities on treatment has not been studied...
- The year in gout: 2011-2012Daria B Crittenden
Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA
Bull NYU Hosp Jt Dis 70:145-51. 2012..Here we review some of the most important recent advances in gout over the past 12 to 18 months...
- Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way streetElaine Karis
From the Division of Rheumatology, Crystal Diseases Study Group, New York University School of Medicine Langone Medical Center, and the Department of Medicine, Rheumatology Section, New York Harbor Veterans Affairs Healthcare System, New York, New York
South Med J 107:235-41. 2014..The evidence that gout and hyperuricemia contribute to the pathogenesis of their comorbidities creates greater urgency for appropriate gout management. ..
- The crystallization of monosodium urateMiguel A Martillo
Divisions of Rheumatology, Department of Medicine, NYU School of Medicine, New York, USA
Curr Rheumatol Rep 16:400. 2014..We also briefly compare MSU biology to that of uric acid stones causing nephrolithasis, and consider the potential treatment implications of MSU crystal biology. ..
- The year in gout - 2010-2011Daria B Crittenden
Rheumatology Section, New York Harbor VA Healthcare System New York Campus, New York, New York, USA
Bull NYU Hosp Jt Dis 69:257-63. 2011....